Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | September 6, 2005 | ||||
Last Updated Date | January 6, 2009 | ||||
Start Date † | August 1999 | ||||
Current Primary Outcome Measures † |
Total wake time at night, wake time after sleep onset, sleep latency, and percent of total sleep in stages 1, 2, 3, 4 and rapid eye movement as measured by in-home polysomnography collected at baseline, 6 months, and 12 months [ Time Frame: 12 months ] [ Designated as safety issue: No ] | ||||
Original Primary Outcome Measures † | Same as current | ||||
Change History | Complete list of historical versions of study NCT00149747 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures † |
|
||||
Original Secondary Outcome Measures † |
|
||||
Descriptive Information | |||||
Brief Title † | The Effectiveness of Regular Exercise on Improving Sleep in Older Adults | ||||
Official Title † | Promoting Exercise, Sleep and Well-Being in Older Adults | ||||
Brief Summary | This study will evaluate the effect of regular aerobic exercise on improving sleep in older adults with moderate difficulty sleeping. |
||||
Detailed Description | Sleep deprivation is a common problem among older adults. It is often at the root of increased mortality and some psychiatric disorders. Regular participation in a medium-intensity exercise regimen may help people sleep better. This study will assess the effectiveness of a regular exercise program on improving sleep in older adults with moderate difficulty sleeping. Participants will be randomly assigned to one of two conditions. One group will partake in a moderate-intensity physical activity training regimen. The other group will act as a non-exercise attention-control comparison group. Each group will undergo its assigned treatment for 12 months. Sleep quantity and quality will be measured objectively using in-home polysomnography. Subjective sleep quality and health-related quality of life measures will be evaluated with questionnaires. All measurements will be performed at the beginning of the study, Month 6, and Month 12. |
||||
Study Phase | Phase II, Phase III | ||||
Study Type † | Interventional | ||||
Study Design † | Treatment, Randomized, Single Blind (Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study | ||||
Condition † |
|
||||
Intervention † |
|
||||
Study Arms / Comparison Groups |
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Completed | ||||
Enrollment † | 66 | ||||
Completion Date | September 2003 | ||||
Primary Completion Date | September 2003 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 55 Years and older | ||||
Accepts Healthy Volunteers | Yes | ||||
Contacts †† | |||||
Location Countries † | United States | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00149747 | ||||
Responsible Party | Abby C. King, Principal Investigator, Stanford University | ||||
Secondary IDs †† | DAHBR HB-C | ||||
Study Sponsor † | National Institute of Mental Health (NIMH) | ||||
Collaborators †† | |||||
Investigators † |
|
||||
Information Provided By | National Institute of Mental Health (NIMH) | ||||
Verification Date | February 2008 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |